NCT03423173 - Lot-to-lot Consistency of 3 Lots of Tetravalent Dengue Vaccine (TDV) in Non-endemic Country(Ies) for Dengue | Biotech Hunter

Enrollment

923

Participants

Timeline

Start Date

February 12, 2018

Primary Completion Date

August 3, 2018

Study Completion Date

January 14, 2019

Conditions

Dengue Fever

Interventions

BIOLOGICAL

TAK-003

TDV subcutaneous injection

BIOLOGICAL

Placebo

TDV Placebo-matching normal saline (0.9% NaCl) subcutaneous injection

Trial Locations (14)

Optimal Research, Rockville

Optimal Research, Huntsville

Synexus Limited - Columbus, Columbus

Synexus Limited- Council Bluffs, Council Bluffs

Synexus Limited - Minneapolis, Edina

Optimal Research, Peoria

Synexus Limited - St. Louis, St Louis

Heartland Research Associates LLC - Augusta, Augusta

Heartland Research Associates LLC, Park City

Advanced Clinical Research, Boise

Advanced Clinical Research, West Jordan

Advanced Clinical Research, Salt Lake City

Clinical Research Center of Nevada, Las Vegas

Anaheim Clinical Trials, LLC, Anaheim